We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 20, 2020

Adjuvant Chemoradiation vs Radiation Alone in HPV-Negative N2a Head and Neck Cancer

JAMA Otolaryngology -- Head & Neck Surgery


Additional Info

JAMA Otolaryngology -- Head & Neck Surgery
Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer
JAMA Otolaryngol Head Neck Surg 2020 Aug 13;[EPub Ahead of Print], F Yan, H Li, JM Kaczmar, AK Sharma, TA Day, DM Neskey, P Pipkorn, J Zenga, EM Graboyes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading